About Tirzepatide (Zepbound) Injection

Zepbound is a once-weekly Tirzepatide Injection approved by the FDA for weight loss in adults with obesity, or those who are overweight with related health problems. It also treats obstructive sleep apnea (OSA) in obese patients.

How Tirzepatide Works

Tirzepatide is a dual GIP and GLP-1 receptor agonist. It activates both hormone receptors to:

• Increase insulin release when blood sugar is high

• Suppress appetite and reduce cravings

• Slow gastric emptying, keeping you full longer

• Support long-term weight loss and blood sugar balance

Clinical Results

• Patients on 15mg weekly lost an average of 23.6 kg (52 lbs) in 72 weeks

• Patients on 10mg weekly lost 22.2 kg (48.9 lbs)

• Patients on 5mg weekly lost 16.1 kg (35.5 lbs)

• Placebo patients lost just 2.4 kg (5.3 lbs)

Uses of Tirzepatide Zepbound Injection

• Weight loss in adults with obesity or overweight

• Long-term weight maintenance

• Management of obstructive sleep apnea (OSA) in obesity

Benefits

• FDA-approved and clinically proven

• Significant and sustained weight loss

• Improves insulin sensitivity & blood sugar control

• Reduces appetite and overeating

• Treats sleep apnea in obese adults

How to Use

• Inject once weekly under the skin (abdomen, thigh, or upper arm)

• Rotate injection sites to prevent irritation

• Take on the same day each week

Side Effects

• Nausea, diarrhea, constipation

• Abdominal pain, vomiting

• Indigestion, decreased appetite

  Most are mild and improve over time. Consult your doctor if persistent.

Safety Advice

• Pregnancy/Breastfeeding: Not recommended

• Contraindications: Do not use if you have thyroid cancer history (MEN2)

• Drug interactions: May reduce effectiveness of oral contraceptives – use barrier method

Storage

• Store in refrigerator (2°C–8°C)

• Do not freeze

• Keep away from children